NLS Pharmaceutics AG (NLSP)
Oct 30, 2025 - NLSP was delisted (reason: merged into NCEL)
0.7620
+0.0220 (2.97%)
Inactive · Last trade price on Oct 30, 2025
NLS Pharmaceutics AG Employees
As of December 31, 2021, NLS Pharmaceutics AG had 7 total employees, including 6 full-time and 1 part-time employees.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$887,719
Market Cap
31.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 7 | - | - |
NLSP News
- 2 months ago - NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd. - PRNewsWire
- 2 months ago - NLS Pharmaceutics Ltd. and Kadimastem Ltd. - PRNewsWire
- 2 months ago - NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs - PRNewsWire
- 2 months ago - NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger - PRNewsWire
- 2 months ago - NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem - PRNewsWire
- 2 months ago - NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares - PRNewsWire
- 2 months ago - NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies - PRNewsWire
- 2 months ago - NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 - PRNewsWire